follow us

follow us

Conference Overview

The Global Clinical Trials Connect 2022 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This multidisciplinary program involves broad participation of people from clinical trials community from around the globe who are focused on learning more about clinical research, clinical trials planning and management.

 

The Pharma and Bio-Tech companies are consistently evolving and new clinical studies, technologies and advancements in care and treatments have augmented the efficiency and at the same time the complexity of clinical trials has increased, with tests being carried out in a highly structured and closely coordinated manner. It is high time that we look into innovative strategies, new technologies, effective and quality collaborations to address these issues, which can cater to the needs of the patient and the industry.

 

This conference intends to focus on the global health and clinical trials around the world. Bioethics, regulations, patient recruitment, site selection, real-world data, data integration & Strategy, outsourcing, vendor management, quality (QbD) in Trial Conduct, risk-based monitoring, clinical auditing & financial planning and other significant topics that play a key role in clinical trials will be addressed along with innovative sessions on new technologies, effective and quality collaborations.

Request Brochure

Sponsors

Media partner

This program will certainly educate health care scientists on trial design, operations, organizing trials, research computing, regulatory aspects, report on clinical trials and gain a better knowledge of the implications of clinical trials in prevention, diagnosis, clinical trial-related ethics and disease treatments.

 

The summit will facilitate an invaluable networking opportunities with decision makers and focus on real case studies, insightful presentations and round tables.

 

It gives us a great pleasure in welcoming you to the Global Clinical Trials Connect 2022.

 


Conference Streams Include

 

 

Globalisation in Clinical Trials

Optimizing Trial Design

Patient Recruitment & Retention

Site Selection & Feasibility

Patient Engagement & Patient Experience

Partnerships & Outsourcing

Clinical Trial Budgets and Contracts

Quality & Compliance

Risk based Trial Management

Clinical
Operations

Clinical Trial Regulation

Data
Management

Tech-Driven Clinical Trials

Decentralized Clinical Trials

Future Clinical
Trials

 

 

 

KEY DISCUSSIONS WE'LL BE EXPLORING

  • Patient Recruitment and Site selection
  • Innovative trial designs
  • Partnership & Collaboration - Sponsors, CROs, Sites and External Vendors
  • Patient centric clinical trials
  • Making Patient Engagement a Reality
  • New innovations in Patient Recruitment planning and execution on a clinical trial
  • Outsourcing strategies and models
  • Electronic Clinical Outcome Assessment and Electronic Patient Reported Outcome
  • Streamlined IRT development process
  • Pharmacovigilance & Clinical Trials
  • Post-Clinical Trial closed communities
  • How to future proof your clinical operations
  • Implementing Risk Based Monitoring
  • Streamlining R&D and lower costs in clinical trials
  • Adaptive Trial Model
  • Clinical Trial Auditing
  • Real World Clinical Trial Strategies
  • Data Quality & Technology
  • Clinical Data Strategy & Analytics
  • Electronic Data Capture (EDC) Systems
  • Decentralised Clinical Trials
  • Clinical Technology and Driving Innovation
  • M-Health, Wearable and Consumer Technology
  • Big-Data, IoT and Artificial Intelligence in Clinical trials
  • Blockchain technology for improving clinical research quality

 


WHO SHOULD ATTEND THE CONFERENCE

 

This event is designed for senior level attendees from various companies including Pharmaceutical, Bio-Tech, Bio-Pharma, CRO’s, Investigative Sites, Solution provider and Government institutions.

 

Attendees includes VPs, GMs, Directors, Heads and Managers of

  • Clinical Trials
  • Clinical Study Management
  • Clinical Operations
  • Clinical Research
  • Patient Organizations
  • Patient Recruitment
  • Outsourcing
  • Vendor Management
  • Site Management
  • Site Monitoring
  • Clinical Pharmacology
  • Clinical Data Management
  • Risk Monitoring
  • EDC
  • Clinical/Digital Innovation
  • Clinical Design/Protocol design/ Strategy makers
  • Clinical Research Sites
  • CROs and CMOs
  • Hospitals/ Associations
  • Regulatory affairs 

 

 

pharmaceutical companies

Speakers

VIEW ALL

There are plenty of opportunities to position yourself as a thought leader & showcase your company.

For enquiries on speaker opportunities please e-mail to speaker@corvusglobalevents.com

Become a Speaker


Wednesday - 21st September 2022 (Time Zone - BST) - Virtual Conference

  • 09:30

  • Welcome Address & Platform Orientation - Orientation will focus on how to access and navigate the virtual conference platform for Live Sessions & Interactive Networking

  • 09:40

  • Chairperson’s opening remarks

    Nancy Meyerson-Hess

    Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
     eMQT

  • 09:50

  • Deploying a DCT in Europe – learnings from the IMI Trials@Home Initiative

    Rebecca Jackson

    Rebecca Jackson Sr. Mgr. Clinical R&D Innovation & Novel Modalities IT
     Janssen Pharmaceutical

  • 10:15

  • How better engage HCPs and patient through digital tools ?

    Stefania Alvino

    Stefania Alvino Omnichannel Marketing Manager & Digital Orchestrator
     Daiichi Sankyo Italia S.p.A

  • 10:40

  • How the World Health Organization’s International Clinical Trials Registry Platform (ICTRP) is improving research transparency globally.

    Ghassan Karam

    Ghassan Karam Project Manager
     World Health Organization

  • 11:05

  • Building patient-centric early phase clinical trials

    • The current state of standardization and reuse of datasets
    • The impact of interoperability and reusable data researcher workflow, drug development timelines and patient experience
    Floris Morang

    Floris Morang Director of Business Development
     Castor

    Iain Little

    Iain Little Team Head IRT Management
     Novartis

Patient Recruitment & Site Selection

  • 11:30

  • Situationally Adaptive Trials - Ukraine Crisis

    Francis Crawley

    Francis Crawley Executive Director
     Good Clinical Practice Alliance - Europe (GCPA)

  • 11:55

  • Advanced analytic technologies for predictive modelling and optimizing patient recruitment in clinical trials

    • Analytic modelling and forecasting patient recruitment
    • Optimal operational design, sites/countries selection given costs & time constraints
    • Data-driven re-projection and optimal adjustment of recruitment to increase probability to meet target
    • Centralized statistical monitoring and detecting unusual data patterns
    • Predicting some operational characteristics
    Vladimir Anisimov

    Vladimir Anisimov Principal Data Scientist, Data Science, Center for Design & Analysis
     Amgen

  • 12:20

  • Virtual Luncheon & Networking - Visit Exhibitor Booths & Network with your peers in our Lounge (Face to Face Video Chats)

     

                

  • 13:00

  • True Global Diversity in our Trials: Africa is Ready

    Shalom Lloyd

    Shalom Lloyd Co-Founder & Chief Strategy Officer
     eMQT

    Tina Barton

    Tina Barton Chief Operating Officer
     eMQT

  • 13:25

  • Trials and Observational Studies

    • How can observational data help RCTs?
    • In what situation can real world studies replace RCTs?   
    • Role of synthetic control arms for one-arm trials
    • Data sources
    • Case studies
    Nawab Qizilbash

    Nawab Qizilbash Clinical Epidemiologist & Head of OXON
     OXON Epidemiology

  • 13:50

  • Medical Affairs and Clinical Operations collaborating on Clinical Trial Optimization

    Eva Gallagher

    Eva Gallagher Vice President, Head of Medical Affairs
     Agios Pharmaceuticals

  • 14:15

  • Panel discussion: Effective patient recruitment and retention in clinical trials to boost trial success

    • What will persuade and impact the patient?
    • Is there anything pharma can provide for a trial member that will increase the value of participation?
    • The aim of patient-driven clinical trials is to diminish the burden of participation by making the participant journey as convenient and pleasant as possible
    • Utilize fitting procedures and techniques to limit dropouts without, in any capacity, constraining a patient to remain in the study
    • Utilize wider use of the innovative statistical and Machine Learning techniques to provide more accurate data-driven forecasting and centralized monitoring of patient recruitment
    Nancy Meyerson-Hess

    Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
     eMQT

    Vladimir Anisimov

    Vladimir Anisimov Principal Data Scientist, Data Science, Center for Design & Analysis
     Amgen

    Carole Scrafton

    Carole Scrafton Patient & Health Advocate
     FibroFlutters

    Lauren Bataille

    Lauren Bataille Head, Digital Medical Capabilities
     Novartis

    Obiageli Onwusaka

    Obiageli Onwusaka Director, Biostatistics
     ClinFocus

  • 14:45

  • Feasibility in clinical trials - the main ingredients

    • Importance of conducting feasibility
    • The stages of clinical trial feasibility
    • Feasibility challenges
    Dex Bilkic

    Dex Bilkic Senior Manager, Site Engagement
     Bayer

Patient Centricity & Patient Engagement

  • 15:10

  • Bringing the patient voice in the design of clinical trials: why, when and how

    Lea Proulx

    Lea Proulx Patient Voice Partner
     Roche

  • 15:35

  • Visit Virtual Exhibitor Booths/Speed Networking at our Exclusive Lounge (Face to Face Video chat with Exhibitors and other attendees)

     

         

  • 15:50

  • Integrating the Patient Voice into Medical Product Development: Opportunities and Applications for the Use of Patient Experience Data

    Jessica Abel

    Jessica Abel Director, Patient Experience Data Policy and Best Practices
     Abbvie

  • 16:15

  • Patient Engagement in Clinical Development - A look at what the UK are doing to bring patients to the forefront of study design

    Alex Hammond

    Alex Hammond Business Development Manager
     NIHR Clinical Research Network

    Kim Down

    Kim Down Business Development Manager
     National Institute of Health and Care Research (NIHR)

  • 16:40

  • The Integration of Patient-Centricity Across the Lifecycle of Treatment Development


    This talk provides a broad view of the rapidly developing landscape of Patient-Centricity in Clinical Research. The audience will learn about a variety of initiatives aimed at improving and accelerating clinical research through collaboration with patients, advocates and their communities.

    • Explore research measuring and evaluating the "Return on Engagement" financial and efficiency value of Patient Centric activities
    • Review key regulatory developments in support of Patient Centered Research
    • Gain insights from the largest global survey on patient and public perceptions and experience in clinical research
    • Examine concrete examples of Patient Centered Research programs and project
    Behtash Bahador

    Behtash Bahador Director, Health Literacy
     CISCRP

  • 17:05

  • What are the benefits of using multi stakeholder approaches, in research, from the patient perspective

    • Why are multi-stakeholder approaches needed and important?
    • Leveraging collaboration to address patients’ needs and challenges
    • The impact of multi-stakeholder approaches on reducing patient burden
    • Patient experience and perspective taking part in multi-stakeholder initiatives
    Carole Scrafton

    Carole Scrafton Patient & Health Advocate
     FibroFlutters

    Hayley Chapman

    Hayley Chapman Senior Program Director
     The Synergist

  • 17:30

  • Quality by Design - what you need to know

    • When/where is it needed
    • What is QbD
    • How to implement
    William Lawton

    William Lawton Consultant
     Risk Based Approach Ltd

  • 17:55

  • Panel discussion: The patient's perspective: why their voice is so important in clinical research

    Nancy Meyerson-Hess

    Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
     eMQT

    Mary Lynne Van Poelgeest-Pomfret

    Mary Lynne Van Poelgeest-Pomfret International patient advocate
     World Federation for Incontinent Patients - WFIP

    Melissa Penn

    Melissa Penn Director, Patient Engagement R&D
     Bayer

    Jost Leemhuis

    Jost Leemhuis Safety Science Partner and Global Business Lead
     Roche

  • 18:25

  • Chairperson’s closing remarks

    Nancy Meyerson-Hess

    Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
     eMQT

  • 18:30

  • Networking - Catch-up with your peers in social lounge


Thursday - 22nd September 2022 (Time Zone - BST) - Virtual Conference

  • 09:40

  • Welcome Address & Platform Orientation - Orientation will focus on how to access and navigate the virtual conference platform for Live Sessions & Interactive Networking

  • 09:50

  • Chairperson’s opening remarks

    Nancy Meyerson-Hess

    Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
     eMQT

  • 10:00

  • Enrolment and retention in clinical studies before and during Covid-19 pandemic: clinical challenges and new opportunities. A case report from a phase 3 clinical program in fibromyalgia

    Domenico Merante

    Domenico Merante Clinical Research Lead TA Orphan-Nephrology
     CSL Vifor

Decentralized Clinical Trials

  • 10:30

  • Patient centric trials to increase Diversity and generate more patient care relevant outcomes from RCTs

    Michael Zaiac

    Michael Zaiac Head of Medical Affairs Oncology Region Europe
     Novartis

  • 11:00

  • Evidence derived from RWD through the application of research methods

    Mohamed Sharaf

    Mohamed Sharaf EMEA Senior Medical Advisor
     Janssen Europe, Middle East & Africa

  • 11:30

  • Governing principles for data management

    Siddhant Ekale

    Siddhant Ekale Enterprise Architect – Clinical Data Management

  • 11:55

  • Global Clinical Development – Complex Generics

    Siddharth Chachad

    Siddharth Chachad Executive Vice President & Head - Global Clinical Management
     Dr. Reddy's Laboratories

  • 12:20

  • Virtual Luncheon & Networking - Visit Exhibitor Booths & Network with your peers in our Lounge (Face to Face Video Chats)

     

                

Quality, Compliance & Risk Management

  • 13:05

  • Are we obsessed with Quality Tolerance Limits?

    • Choosing QTL Parameters wisely
    • Are you asking the right questions when considering the application of Quality Tolerance Limits (QTL)?
    • Controlling risk within diagnostic clinical studies
    Mireille (Zerola) Lovejoy

    Mireille (Zerola) Lovejoy Director of Clinical Risk Management
     GE Healthcare

  • 13:30

  • Navigating and applying risk based approaches in clinical trials

    Laura Galuchie

    Laura Galuchie Senior Director & TransCelerate Program Lead
     MSD

  • 13:55

  • The effectiveness of new generation analytics models in RBM

    • Centralized monitoring can characterize key risk classifications and pointers from all clinical and operational source data available.
    • To evaluate risks to site performance, subject safety and data quality using Data and Analytics
    • Differentiating the relative risks between sites and subjects using the new age analytics models.
    Shawntel Swannack

    Shawntel Swannack Director, Central Monitoring and Data Analytics
     GSK

Outsourcing & Clinical Trials

  • 14:20

    • Manage Phase I studies during pandemic
    • Site resource situation in Early Phase and Sponsor/CRO demands
    • How can Sponsor and CRO decrease demand on healthy volunteers and site resources
    Jan Schmejkal

    Jan Schmejkal Associate Director, Global Trial Leader
     The Janssen Pharmaceutical Companies of Johnson & Johnson

  • 14:45

  • Panel Discussion - A collaborative clinical ecosystem: How to effectively manage partnerships with all Stakeholders including Patients, Sites, CROs, Sponsors and Regulators.

    Nancy Meyerson-Hess

    Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
     eMQT

    Oscar Segurado

    Oscar Segurado Chief Medical Officer
     ASC Therapeutics

    Katie Madden

    Katie Madden Senior Manager, Digital and Process Optimization
     GSK

  • 15:15

  • Visit Virtual Exhibitor Booths/Speed Networking at our Exclusive Lounge (Face to Face Video chat with Exhibitors and other attendees)

     

         

Clinical Data & Tech Driven Clinical Trials

  • 15:40

  • FDA draft guidance on 'Digital Health Technologies for Remote Data Acquisition in Clinical Investigations

    Benoit Marchal

    Benoit Marchal Chief Digital Trust Officer
     Partners for Patients

  • 16:05

  • Making Decentralizing Clinical Trials Pragmatic with AI and Wearables

    Maria Palombini

    Maria Palombini Leader, Healthcare Life Sciences Practice
     IEEE Standards Association

  • 16:30

  • Statistics and Data Science in the Research and Development (R&D) department of a pharmaceutical company

    Meritxell Falques Casanovas

    Meritxell Falques Casanovas Head of Global Statistics
     Almirall

  • 16:55

  • Panel Discussion: The Future of Clinical Trials - The Role of Advanced Analytics and Artificial Intelligence

    Nancy Meyerson-Hess

    Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
     eMQT

    Bhupathy Alagiriswamy

    Bhupathy Alagiriswamy Director
     Credence Clinical Solutions Ltd

    Jessica Riggleman

    Jessica Riggleman Sr. Director, Clinical and Regulatory Affairs
     Mydecine Innovations Group

    Siddhant Ekale

    Siddhant Ekale Enterprise Architect – Clinical Data Management

  • 17:25

  • Decentralized Clinical Trials and Patient Centricity: Spotlight on Rare Diseases

    • Uses & challenges for Blockchain in Clinical Trials
    • Storing all types of data safely and securely
    • Better Clinical Trials Quality
    Oscar Segurado

    Oscar Segurado Chief Medical Officer
     ASC Therapeutics

  • 17:50

  • Chairperson’s closing remarks

    Nancy Meyerson-Hess

    Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
     eMQT

What do the Pass Include


  •  C-Suite keynote sessions & Panel Discussions
  •  Full 2-day live event Access
  •  Interactive live Video chat
  •  Interactive Social lounge with individual tables for discussions & Exchange of Information
  •  Q&A Session and polling
  •  Messaging meetings and networking with Industry Experts and Peers
  •  Access to Virtual expo (including videos, reports and articles from solution providers),
  •  Receiving Handouts
  •  On demand event recordings until 1 month
  •  Certificate for attending

BRING YOUR TEAM
Delegate Registration

Corvus Global Events recognises the value of learning in teams. There's so much great content!!!

Bring your team and get an extra discount. There are special group packages available. Please email to delegate@corvusglobalevents.comfor more details.

register now

PARTNERS

Partnerships typically involve an exchange of value and frequently include online content, PR, advertising, online & event branding.

For enquiries please e-mail to mediapartner@corvusglobalevents.com

Testimonials


Sanofi
Global Lead, Clinical Innovation & External Partnership


It helps keeping all of us connected and offer a place for sharing new knowledge and interacting within the research community.




Saphetor
Marketing Manager


The agenda was the best in the industry for this topic. The calibre of speaker was superb, and the content delivered was equally good. If the agenda is always this good, then this is a must attend event for anyone needing to calibrate themselves and make sure they know and understand the challenges around modern clinical trials and feel like you're in the right place to find the solutions.




Janssen Pharmaceutical
Associate Director Global Clinical Development Operations Trial Lead


Well organised event, with very interesting speakers and a lot of interaction not just during the breaks but also during the meeting. I enjoyed that the event




Amgen
Executive Director Biostatistics, Global Biostatistical Science, Center for Design and Analysis


There was an excellent range of topics discussed, and I particularly enjoyed the focus on patient perspectives in how clinical research sites can optimise their interactions with patients by using a range of communication tools. The conference provided me with many opportunities to network with the other participants.




Clinical Trial Center Spa
Head of Site Management Organization (SMO) Unit


Great contents, high quality presentations and superb speakers, able to involve the audience and to make serious topics catchy. I found this event to be really useful and informative, with valuable networking and the right commercial side: well centered and non invasive



VIRTUAL PLATFORM

 

Our interactive platform has many rich features and they are a great experience for the users with Networking Video Chat, Polling, Raise Hand, Virtual Exhibitor booths with waiting room/tables, Q&A Sessions with industry experts, virtual chat, Peer to Peer connect at Social Lounge and Handout Bag

Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now